Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Acorda Therapeutics Inc    ACOR   US00484M1062

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/21/2014 11/24/2014 11/25/2014 11/26/2014 11/28/2014 Date
35.94(c) 36.41(c) 36.5(c) 36.81(c) 36.45(c) Last
465 410 546 054 415 888 370 286 236 578 Volume
-0.42% +1.31% +0.25% +0.85% -0.98% Change
More quotes
Company
Acorda Therapeutics, Inc. engages in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the nervous system.The company's two main products are Ampyra and Zanaflex... 
Surperformance© rating of Acorda Therapeutics Inc
Trading Rating : Investor Rating :
More about the company
Chart ACORDA THERAPEUTICS INC
Duration : Period :
Acorda Therapeutics Inc Technical Analysis Chart | ACOR | US00484M1062 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 385 M
EBIT 2014 42,2 M
Net income 2014 20,1 M
Debt 2014 -
Yield 2014 -
Sales 2015 412 M
EBIT 2015 21,3 M
Net income 2015 6,36 M
Debt 2015 -
Yield 2015 -
PER 2014 78,32
PER 2015 152,55
Capi. / Sales 2014 4,01x
Capi. / Sales 2015 3,75x
Capitalization 1 544 M
More Financials
Latest news on ACORDA THERAPEUTICS INC
2d ago ACORDA THERAPEUTICS : Studies from Acorda Therapeutics Yield New Information abo..
2d ago ACORDA THERAPEUTICS : Patent Issued for Formulations for the Treatment of Pain
11/20 ACORDA THERAPEUTICS : Assigned Patent
11/19 ACORDA THERAPEUTICS : to Participate at the Jefferies 2014 Global Healthcare Con..
11/14 ACORDA THERAPEUTICS : to Present at the Jefferies 2014 Global Healthcare Confere..
11/12 ACORDA THERAPEUTICS : to Present at the Stifel 2014 Healthcare Conference
11/05 ACORDA THERAPEUTICS : Reports Third Quarter 2014 Financial Results
11/04 ACORDA THERAPEUTICS : to Present at the Credit Suisse 2014 Healthcare Conference
11/04 ACORDA THERAPEUTICS : Posts 3Q 2014 Financial Results
10/31 ACORDA THERAPEUTICS : Reports Third Quarter 2014 Financial Results
10/31 ACORDA THERAPEUTICS : Buys Civitas Therapeutics
10/30 ACORDA THERAPEUTICS : tops 3Q revenue forecasts
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF